tiprankstipranks
Trending News
More News >

Cardiex Launches $4.1 Million Entitlement Offer to Boost Vascular Health Innovations

Story Highlights
  • Cardiex has announced a new share entitlement offer to raise $4.1 million.
  • The offer aims to enhance Cardiex’s financial position for advancing vascular health technologies.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cardiex Launches $4.1 Million Entitlement Offer to Boost Vascular Health Innovations

Confident Investing Starts Here:

An announcement from CardieX ( (AU:CDX) ) is now available.

Cardiex Limited has announced the dispatch of its Entitlement Offer Booklet for a fully underwritten non-renounceable pro rata entitlement offer of new shares. The offer aims to raise approximately $4.1 million before costs, with a closing date set for June 20, 2025. This initiative is expected to strengthen Cardiex’s financial position and support its ongoing efforts in advancing vascular health technologies.

More about CardieX

Cardiex is a company focused on medical technology advancements in vascular health. It offers a range of products including medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders, leveraging its SphygmoCor® vascular biomarker technology. Cardiex is listed on the Australian Stock Exchange (ASX:CDX).

Average Trading Volume: 245,823

Technical Sentiment Signal: Sell

Current Market Cap: A$22.33M

Learn more about CDX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1